Jabbari Moghaddam Yalda, Golzari Samad E J, Saboktakin Lida, Seyedashrafi Mir Hojjat, Sabermarouf Babak, Gavgani Heidar Ali Esmaeili, Haghjo Amir Ghorbani, Lotfi Alireza, Ghabili Kamyar
Pediatric Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Int J Pediatr Otorhinolaryngol. 2013 Sep;77(9):1541-4. doi: 10.1016/j.ijporl.2013.06.029. Epub 2013 Jul 29.
Adenotonsillar hypertrophy (ATH) contributes to upper airway obstruction and recurrent tonsillitis in children. The aim of this study was to evaluate the effect of adenotonsillectomy on serum IGF-1 and ghrelin levels in children with ATH failure to thrive.
Forty pre-pubertal children with more than 5 years of age (6.57 ± 1.284 years) suffering from ATH, sleep disorder breathing, snoring, open mouth breathing and growth retardation were studied. Blood samples were taken eight hours after fasting and weight and height were measured by SECA instrument. Blood samples were centrifuged immediately and the extracted sera were stored at -70 °C in Eppendorf vials. IGF-1 and ghrelin were measured by ELISA kit. Patients with adenotonsillectomy indication underwent adenotonsillectomy and serum levels of IGF-1 and ghrelin were measured 12 months after operation.
Weight, height and BMI were increased significantly after operation (P < 0.001). Serum IGF-1 and ghrelin levels increased significantly after operation compared to before operation (P < 0.001).
Growth retardation in children with adenotonsillar hypertrophy is related to lower serum IGF-1 levels. Ghrelin levels increase before the meals and ghrelin increases hunger and food intake. The results obtained from our study confirmed that weight, height and BMI increase significantly following adenotonsillectomy; this could in turns prevent undesirable and irreversible physiological changes that occur due to adenotonsillar hypertrophy. Adenotonsillectomy in children with adenotonsillar hypertrophy and failure to thrive increases IGF-1 and Ghrelin serum levels which might contribute to the improvement in the growth pattern of the children.
腺样体扁桃体肥大(ATH)会导致儿童上呼吸道阻塞和复发性扁桃体炎。本研究的目的是评估腺样体扁桃体切除术对患有ATH且生长发育迟缓儿童血清胰岛素样生长因子-1(IGF-1)和胃饥饿素水平的影响。
对40名5岁以上(6.57±1.284岁)青春期前患有ATH、睡眠呼吸障碍、打鼾、张口呼吸和生长发育迟缓的儿童进行研究。空腹8小时后采集血样,并用SECA仪器测量体重和身高。血样立即离心,提取的血清保存在Eppendorf小瓶中,于-70°C保存。采用酶联免疫吸附测定(ELISA)试剂盒检测IGF-1和胃饥饿素。有腺样体扁桃体切除术指征的患者接受腺样体扁桃体切除术,并在术后12个月测量血清IGF-1和胃饥饿素水平。
术后体重、身高和体重指数(BMI)显著增加(P<0.001)。与术前相比,术后血清IGF-1和胃饥饿素水平显著升高(P<0.001)。
腺样体扁桃体肥大儿童的生长发育迟缓与血清IGF-1水平较低有关。胃饥饿素水平在饭前升高,胃饥饿素会增加饥饿感和食物摄入量。我们的研究结果证实,腺样体扁桃体切除术后体重、身高和BMI显著增加;这反过来可以预防由于腺样体扁桃体肥大而发生的不良和不可逆的生理变化。对患有腺样体扁桃体肥大且生长发育迟缓的儿童进行腺样体扁桃体切除术可提高血清IGF-1和胃饥饿素水平,这可能有助于改善儿童的生长模式。